- conflicts or gaps
- [[{"field": {"value": "founders", "source_urls": ["https://www.ycombinator.com/companies/lucira-health", "https://pmc.ncbi.nlm.nih.gov/articles/PMC12461465/"]}, "issue": {"value": "Y Combinator lists only Debkishore Mitra as founder; peer-reviewed case study and UC Berkeley IPIRA list John Waldeisen and Ivan Dimov as co-founders alongside Mitra.", "source_urls": ["https://www.ycombinator.com/companies/lucira-health", "https://pmc.ncbi.nlm.nih.gov/articles/PMC12461465/", "https://ipira.berkeley.edu/lucira-health"]}}, {"field": {"value": "identity.founded_year", "source_urls": ["https://www.sec.gov/Archives/edgar/data/1652724/000119312521031881/d19221d424b4.htm", "https://www.360dx.com/molecular-diagnostics/pfizer-shut-down-lucira-health-business-end-q1", "https://pmc.ncbi.nlm.nih.gov/articles/PMC12461465/"]}, "issue": {"value": "SEC S-1 states Delaware incorporation in February 2013 and operations began 2013; 360Dx says founded in 2012; RSC paper says company started 2013; RSC funding table includes 2012 NIH grant predating incorporation.", "source_urls": ["https://www.sec.gov/Archives/edgar/data/1652724/000119312521031881/d19221d424b4.htm", "https://www.360dx.com/molecular-diagnostics/pfizer-shut-down-lucira-health-business-end-q1", "https://pmc.ncbi.nlm.nih.gov/articles/PMC12461465/"]}}, {"field": {"value": "identity.current_status", "source_urls": ["https://www.ycombinator.com/companies/lucira-health", "https://www.360dx.com/molecular-diagnostics/pfizer-shut-down-lucira-health-business-end-q1"]}, "issue": {"value": "Y Combinator still lists Status as Public; company filed Chapter 11 in February 2023, sold assets to Pfizer in April 2023, and Pfizer discontinued the Lucira product line by Q1 2025.", "source_urls": ["https://www.ycombinator.com/companies/lucira-health", "https://www.globenewswire.com/news-release/2023/02/22/2613806/0/en/Lucira-Health-to-Pursue-Strategic-Sale-of-its-Business-Through-Voluntary-Chapter-11-Process.html", "https://www.360dx.com/molecular-diagnostics/pfizer-shut-down-lucira-health-business-end-q1"]}}, {"field": {"value": "funding.total_raised_usd", "source_urls": ["https://pmc.ncbi.nlm.nih.gov/articles/PMC12461465/", "https://www.cbinsights.com/company/diassess/financials", "https://golden.com/wiki/Lucira_Health-ZXY66DR"]}, "issue": {"value": "RSC peer-reviewed table totals $284,627,693 (dilutive + non-dilutive); CB Insights reports $50.42M over 11 VC rounds; Golden wiki reports ~$52M-$37M depending on field — definitions differ between all capital vs VC-only.", "source_urls": ["https://pmc.ncbi.nlm.nih.gov/articles/PMC12461465/", "https://www.cbinsights.com/company/diassess/financials", "https://golden.com/wiki/Lucira_Health-ZXY66DR"]}}, {"field": {"value": "funding.rounds Series B", "source_urls": ["https://pmc.ncbi.nlm.nih.gov/articles/PMC12461465/", "https://www.finsmes.com/2019/08/lucira-health-closes-15m-series-b-financing.html", "https://www.sec.gov/Archives/edgar/data/1652724/000119312521031881/d19221d424b4.htm"]}, "issue": {"value": "Multiple Series B events: March 2019 preferred financing ~$32.5M total per RSC (incl. note conversions) vs publicly reported $15M Series B equity round in August 2019; sources use 'Series B' for both.", "source_urls": ["https://pmc.ncbi.nlm.nih.gov/articles/PMC12461465/", "https://www.finsmes.com/2019/08/lucira-health-closes-15m-series-b-financing.html", "https://www.sec.gov/Archives/edgar/data/1652724/000119312521031881/d19221d424b4.htm"]}}, {"field": {"value": "identity.renamed_to_lucira", "source_urls": ["https://www.sec.gov/Archives/edgar/data/1652724/000119312521031881/d19221d424b4.htm", "https://www.jitta.com/stock/NASDAQ:LHDX"]}, "issue": {"value": "SEC S-1 states name change to Lucira Health in April 2019; Jitta and other secondary sources say January 2020.", "source_urls": ["https://www.sec.gov/Archives/edgar/data/1652724/000119312521031881/d19221d424b4.htm", "https://www.jitta.com/stock/NASDAQ:LHDX"]}}, {"field": {"value": "employees.snapshots", "source_urls": ["https://www.ycombinator.com/companies/lucira-health", "https://www.360dx.com/business-news/lucira-health-files-chapter-11-bankruptcy-signals-intent-sell-business", "https://www.sec.gov/Archives/edgar/data/1652724/000119312523092209/d462703dex991.htm"]}, "issue": {"value": "YC reports team_size 43 (undated/stale); 360Dx reports ~225 before Oct 2022 layoffs; SEC bankruptcy filing reports 61 FTE at Feb 2023.", "source_urls": ["https://www.ycombinator.com/companies/lucira-health", "https://www.360dx.com/business-news/lucira-health-files-chapter-11-bankruptcy-signals-intent-sell-business", "https://www.sec.gov/Archives/edgar/data/1652724/000119312523092209/d462703dex991.htm"]}}, {"field": {"value": "exit_status.post_exit shutdown timing", "source_urls": ["https://www.360dx.com/molecular-diagnostics/pfizer-shut-down-lucira-health-business-end-q1", "https://pmc.ncbi.nlm.nih.gov/articles/PMC12461465/"]}, "issue": {"value": "360Dx reports Pfizer to shut down Lucira business by end of Q1 2025; RSC epilogue says product sale ended in March 2025 — consistent but not identical phrasing.", "source_urls": ["https://www.360dx.com/molecular-diagnostics/pfizer-shut-down-lucira-health-business-end-q1", "https://pmc.ncbi.nlm.nih.gov/articles/PMC12461465/"]}}, {"field": {"value": "products Lucira COVID-19 & Flu Home Test EUA clinical data", "source_urls": ["https://www.fda.gov/medical-devices/medical-devices-news-and-events/cdrh-statement-emergency-use-authorization-lucira-healths-covid-19-flu-home-test", "https://pmc.ncbi.nlm.nih.gov/articles/PMC12461465/"]}, "issue": {"value": "Lucira CEO cited protracted FDA authorization; FDA CDRH statement noted toxic buffer component (guanidine hydrochloride) and insufficient influenza A clinical samples (35 vs 50 requested; original submission had 9).", "source_urls": ["https://www.fda.gov/medical-devices/medical-devices-news-and-events/cdrh-statement-emergency-use-authorization-lucira-healths-covid-19-flu-home-test", "https://pmc.ncbi.nlm.nih.gov/articles/PMC12461465/"]}}]]
- source urls
- ["https://bulletin.webull.com/20230424/252751/faf4a6d741e9460fae4a118795ec5f90.html", "https://data/startup_data/export/ontonym_startups/objects.jsonl", "https://finance.yahoo.com/news/remember-lucira-healths-30-minute-182748543.html", "https://golden.com/wiki/Lucira_Health-ZXY66DR", "https://ipira.berkeley.edu/lucira-health", "https://pmc.ncbi.nlm.nih.gov/articles/PMC12461465/", "https://today.ucsd.edu/story/uc-san-diego-alumnus-at-helm-of-company-behind-first-at-home-covid-test", "https://tracxn.com/d/companies/lucirahealth/__-NB0COSsjhcUVi0qQLQ7chMx9VeXmG7AfXf16LCkaIU", "https://www.360dx.com/business-news/lucira-health-closes-15m-series-b-financing", "https://www.360dx.com/business-news/lucira-health-files-chapter-11-bankruptcy-signals-intent-sell-business", "https://www.360dx.com/molecular-diagnostics/pfizer-shut-down-lucira-health-business-end-q1", "https://www.biopharmadive.com/news/coronavirus-fda-lucira-eua-first-home-test/589303/", "https://www.biospace.com/lucira-health-inc-completes-series-b-financing", "https://www.businesswire.com/news/home/20210209006142/en/Lucira-Health-Announces-Closing-of-its-Upsized-Initial-Public-Offering-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares", "https://www.cbinsights.com/company/diassess/financials", "https://www.fda.gov/media/147492/download", "https://www.fda.gov/media/186158/download", "https://www.fda.gov/medical-devices/medical-devices-news-and-events/cdrh-statement-emergency-use-authorization-lucira-healths-covid-19-flu-home-test", "https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-covid-19-test-self-testing-home", "https://www.finsmes.com/2019/08/lucira-health-closes-15m-series-b-financing.html", "https://www.globenewswire.com/news-release/2023/02/22/2613806/0/en/Lucira-Health-to-Pursue-Strategic-Sale-of-its-Business-Through-Voluntary-Chapter-11-Process.html", "https://www.govinfo.gov/content/pkg/FR-2025-05-29/html/2025-09678.htm", "https://www.govinfo.gov/content/pkg/FR-2026-01-02/html/2025-24155.htm", "https://www.jitta.com/stock/NASDAQ:LHDX", "https://www.lucirahealth.com/", "https://www.nsmedicaldevices.com/analysis/lucira-health-company/", "https://www.sec.gov/Archives/edgar/data/1652724/000119312521029315/d87743ds1mef.htm", "https://www.sec.gov/Archives/edgar/data/1652724/000119312521031881/d19221d424b4.htm", "https://www.sec.gov/Archives/edgar/data/1652724/000119312523092209/d462703dex991.htm", "https://www.shangbaycapital.com/lucira-health", "https://www.vcnewsdaily.com/Lucira%20Health/venture-funding.php", "https://www.warntracker.com/company/lucira-health", "https://www.ycombinator.com/companies/lucira-health"]